Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: ratziu v. J Hepatol. 2024 Apr;80(4):531-533. doi: 10.1016/j.jhep.2024.01.017. J Hepatol. 2024. PMID: 38494309 No abstract available.
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.
Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Munson ML, Chen YC, Najera I, Thommes J; PROPEL Investigators. Wedemeyer H, et al. Hepatology. 2013 Aug;58(2):524-37. doi: 10.1002/hep.26274. Epub 2013 Jun 26. Hepatology. 2013. PMID: 23348636 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 38182319
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: ratziu v. J Hepatol. 2024 Feb;80(2):173-175. doi: 10.1016/j.jhep.2023.12.012. J Hepatol. 2024. PMID: 38278620 No abstract available.
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: ratziu v. J Hepatol. 2024 Mar;80(3):381-383. doi: 10.1016/j.jhep.2024.01.001. J Hepatol. 2024. PMID: 38368017 No abstract available.
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: ratziu v. J Hepatol. 2024 May;80(5):673-675. doi: 10.1016/j.jhep.2024.02.024. J Hepatol. 2024. PMID: 38637103 No abstract available.
From the Editor's Desk..
Burra P, Tacke F, Ratziu V, Zeuzem S, Sangro B, Angeli P. Burra P, et al. Among authors: ratziu v. J Hepatol. 2024 Jun;80(6):829-831. doi: 10.1016/j.jhep.2024.04.001. J Hepatol. 2024. PMID: 38760150 No abstract available.
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P; ION-1 Investigators. Afdhal N, et al. N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11. N Engl J Med. 2014. PMID: 24725239 Free article. Clinical Trial.
406 results